Voice Recognition Experts Offer Implementation Tips
Despite some of the proven benefits of voice recognition software, some radiologists still struggle to fit the software into their workflow. Here are some tips from some top VR developers.
Despite some of the proven benefits of voice recognition software, some radiologists still struggle to fit the software into their workflow. Here are some tips from some top VR developers.
1. Designate a champion. Just as with other major technology implementations, your department or practice should have a strong leader that believes in the software and sees its benefits, said GE Healthcare product manager Tim Kearns. That person can really help drive adoption.
2. Take stock of your radiologists and workflow before implementing. “Think through a change management plan,” said Jacques Gilbert, global marketing manager for radiology for GE Healthcare. And make sure you’ve communicated to the entire department or practice just why you’re making the transition.
3. Consider two waves of adopters. Assess who might be less inclined to jump on the VR bandwagon, and who might want to hang on to the transcriptionist for a bit longer. Then graduate the less inclined after the first group has proven the software’s success. Benchmarking their improved turnaround time might add a bit of peer pressure to encourage those who are dragging their feet, Gilbert said.
Cadet agreed with a phased in approach. “For an organization that keeps a transcriptionist on board, you can ease into it. Have some do it, others not, and in time the others will often make their way into it,” he said.
4. Don’t fear the technology. M*Modal’s Don Fallati encouraged radiologists not to be daunted by past experiences with the technology or old horror stories. “The amount of physician training and enrollment are much quicker than they ever were in the past,” he said.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
